13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0001104659-25-048527
Total Value
$521.8M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kymera Therapeutics, Inc. | KYMR | 4,896,462 | $134.0M | 25.69% |
| 2 | Disc Medicine, Inc. | IRON | 2,384,456 | $118.4M | 22.69% |
| 3 | Dyne Therapeutics, Inc. | DYN | 9,130,465 | $95.5M | 18.30% |
| 4 | Day One Biopharmaceuticals, Inc. | DAWN | 6,430,257 | $51.0M | 9.77% |
| 5 | Sionna Therapeutics, Inc. | SION | 3,694,020 | $38.6M | 7.41% |
| 6 | Third Harmonic Bio, Inc. | 88427A107 | 10,402,286 | $36.1M | 6.92% |
| 7 | Korro Bio, Inc. | KRRO | 1,137,149 | $19.8M | 3.79% |
| 8 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $10.4M | 1.99% |
| 9 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $6.4M | 1.23% |
| 10 | Aerovate Therapeutics, Inc. | 008064107 | 1,799,232 | $4.5M | 0.87% |
| 11 | Q32 Bio, Inc. | QTTB | 2,092,106 | $3.5M | 0.66% |
| 12 | Generation Bio, Co. | 37148K100 | 8,279,484 | $3.4M | 0.64% |
| 13 | Spero Therapeutics, Inc. | SPRO | 305,255 | $219,784 | 0.04% |